Search Results for "Brilinta Sales"
Original Source: ESC ranking puts AstraZeneca's Brilinta ahead of Lilly's Effient and clopidogrel
The European Society of Cardiology has backed the use of AstraZeneca's new oral antiplatelet agent ticagrelor (Brilinta/Brilique), giving it its highest class 1 recommendation in its latest guidelines for the treatment of ST-elevation acute.....
Matching Channels
Brilinta (TM) - ticagrelor, AstraZeneca's new heart drug
Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...
Pfizer is a global pharmaceutical company, the largest in world based on annual sales. In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have...
Boehringer Ingelheim is a global pharmaceutical company with annual sales of over $16 billion, making it the 10th largest pharmaceutical company in the world based on sales. With bases in 47 c...
Plavix is a clot-busting drug, produced by Bristol-Myers Squibb Company, and reached annual sales in 2009 of $4.2m, making the third highest drug in the world (based on 2009 annual sales). Prescri...
Matching News
AstraZeneca gains rights for Brilinta to treat acute acute coronary syndrome in China
China’s State Food and Drug Administration has issued an drug import licence for the product, meaning it will now be available for treating patients with acute coronary syndrome in the country....
AstraZeneca: SocGen says 'sell' after predicting less than brilliant outlook for Brilinta
SoGen has repeated its ‘sell’ recommendation and £26.75 share price target for pharma giant AstraZeneca (LON:AZN). Its negativity is based around what it expects to be the less-than...
Brilinta Added to Recommended Agents for MI (CME/CE)
(MedPage Today) -- Two medical societies have updated their joint guideline for the management of non-ST-segment MI and unstable angina to include the most recently approved anti-platelet agent, ticag...
AstraZeneca Aims To Shake Plavix Off The Throne With Launch Of Brilinta In China
AstraZeneca launches Brilinta in China, aiming to grow its share of a $1.5 billion antithrombotic market at the expense of Sanofi’s Plavix.
BRIEF-AstraZeneca CEO says Brilinta can do "far better"
LONDON, Oct 25 (Reuters) - AstraZeneca PLC : * New CEO says believes Brilinta is best product and can do far better than has
AstraZeneca plans trial to compare Brilinta and Plavix for PAD
AstraZeneca will initiate a global clinical trial to compare the efficacy of Brilinta against Sanofi and Bristol-Myers Squibb -More-
AstraZeneca Wins China Approval of Heart Drug
AstraZeneca was given SFDA approval for Brilinta, a drug that helps prevent blood clots, for patients with acute coronary syndrome. Brilinta was approved in the EU in 2010 and the US in 2011. Altho...
ESC ranking puts AstraZeneca's Brilinta ahead of Lilly's Effient and clopidogrel
The European Society of Cardiology has backed the use of AstraZeneca's new oral antiplatelet agent ticagrelor (Brilinta/Brilique), giving it its highest class 1 recommendation in its latest guidelin...
Matching PubMed Articles
The relationship between sales of SSRI, TCA and suicide rates in the Nordic countries.
ABSTRACT: BACKGROUND: In the period 1990-2006, strong and almost equivalent increases in sales figures of selective serotonin re-uptake inhibitors (SSRIs) were observed in all Nordic countries. The sa...
ABSTRACT: BACKGROUND: Water utilities continue to be interested in implementing syndromic surveillance for the enhanced detection of waterborne disease outbreaks. The authors evaluated the ability of...
Exercise in Thoroughbred yearlings during sales preparation: A cohort study.
Reasons for performing study: There is increasing evidence suggesting that early exercise in Thoroughbred racehorses may be beneficial to the development of the musculoskeletal system. At present, inf...
OBJECTIVE: To investigate the association between weekly lottery sales and number of suicide deaths in Taiwan. METHODS: All suicides aged 15+ years during 2004-2006 in Taiwan were included. Poisson au...
Environmental strategies to prevent the misuse of alcohol among youth-e.g., use of public policies to restrict minors' access to alcohol-have been shown to reduce underage drinking. However, implement...
